RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Andrew Taylor to Lidocaine

Back to Details
This is a "connection" page, showing publications Andrew Taylor has written about Lidocaine.
Andrew Taylor
Connection Strength
0.104
Lidocaine
  1. Fernando H, Nehme Z, Milne C, O'Brien J, Bernard S, Stephenson M, Myles PS, Lefkovits J, Peter K, Brennan A, Dinh D, Andrew E, Taylor AJ, Smith K, Stub D. LidocAine Versus Opioids In MyocarDial infarction: the AVOID-2 randomized controlled trial. Eur Heart J Acute Cardiovasc Care. 2023 Jan 27; 12(1):2-11.
    View in: PubMed
    Score: 0.055
  2. Fernando H, Milne C, Nehme Z, Ball J, Bernard S, Stephenson M, Myles PS, Bray JE, Lefkovits J, Liew D, Peter K, Brennan A, Dinh D, Andrew E, Taylor AJ, Smith K, Stub D. An open-label, non-inferiority randomized controlled trial of lidocAine Versus Opioids In MyocarDial Infarction study (AVOID-2 study) methods paper. Contemp Clin Trials. 2021 06; 105:106411.
    View in: PubMed
    Score: 0.049
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support